Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
TORONTO — Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms and innovative deliv
(Financial Post, 2025-11-05T12:31:47Z)